Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis

Farragher, TM orcid.org/0000-0002-1968-6378, Lunt, M, Fu, B et al. (2 more authors) (2010) Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis. Annals of the Rheumatic Diseases, 69 (4). pp. 689-695. ISSN 0003-4967

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl
Keywords: RHEUMATOID-ARTHRITIS PATIENTS; HEALTH-ASSESSMENT QUESTIONNAIRE; SURVIVAL ANALYSIS; PROPENSITY SCORE; CLINICAL-TRIALS; DISABILITY; MODELS; LIMITATIONS; COMMUNITY; SELECTION
Dates:
  • Published: 17 March 2010
  • Accepted: 3 October 2009
  • Published (online): 26 October 2009
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 11 Jul 2019 13:04
Last Modified: 11 Jul 2019 13:04
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1136/ard.2009.108639

Share / Export

Statistics